My Chau T. Tran

Array ( [id] => 11479372 [patent_doc_number] => 09585893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Flumazenil complexes, compositions comprising same and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/974760 [patent_app_country] => US [patent_app_date] => 2013-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 14100 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10174448 [patent_doc_number] => 09204633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Using an unsubstituted quatenary ammonium salt composition with other ingredients as a skin sanitizing solution and natural skin conditioner' [patent_app_type] => utility [patent_app_number] => 13/964393 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2765 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281480 [patent_doc_number] => 20150166477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF MTOR PATHWAY RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/420081 [patent_app_country] => US [patent_app_date] => 2013-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 17458 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858530 [patent_doc_number] => 20150038547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'Biological Basis of Adult Wellness' [patent_app_type] => utility [patent_app_number] => 13/956327 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4267 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13956327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870401 [patent_doc_number] => 08895599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Lipoprotein lipase-activating compositions comprising benzene derivates' [patent_app_type] => utility [patent_app_number] => 13/931196 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23455 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9865339 [patent_doc_number] => 20150045358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING DISORDERS ASSOCIATED WITH INSULIN RESISTANCE' [patent_app_type] => utility [patent_app_number] => 13/898524 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 2922 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055344 [patent_doc_number] => 20130253058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'SATIETY-INDUCING COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/890808 [patent_app_country] => US [patent_app_date] => 2013-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17385 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135723 [patent_doc_number] => 20130296438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR USE WITH K-RAS MEDIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/873799 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13873799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10006826 [patent_doc_number] => 09050325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Ondansetron nasal spray composition' [patent_app_type] => utility [patent_app_number] => 13/986152 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1546 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455320 [patent_doc_number] => 08716328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 13/856216 [patent_app_country] => US [patent_app_date] => 2013-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 13016 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13856216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11901019 [patent_doc_number] => 09770440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-26 [patent_title] => 'Solid oral pharmaceutical compositions for isoxazoline compounds' [patent_app_type] => utility [patent_app_number] => 14/390052 [patent_app_country] => US [patent_app_date] => 2013-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8619 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11428007 [patent_doc_number] => 09566310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Methods of treating muscular dystrophy' [patent_app_type] => utility [patent_app_number] => 13/842781 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 35368 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13842781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269707 [patent_doc_number] => 20140024625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'Compositions and methods for using same for improving the quality of the meibum composition of meibomiam glands' [patent_app_type] => utility [patent_app_number] => 13/815599 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10878 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940497 [patent_doc_number] => 20130190294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'COMPOUNDS AND METHODS FOR TREATING DIABETES' [patent_app_type] => utility [patent_app_number] => 13/789376 [patent_app_country] => US [patent_app_date] => 2013-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 180367 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016375 [patent_doc_number] => 20130231339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'BENZOFURAN-2-SULFONAMIDES PYRIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/782174 [patent_app_country] => US [patent_app_date] => 2013-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28657 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016427 [patent_doc_number] => 20130231391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'ADAMANTANE DERIVATIVES POSSESSING ANTI-VIRAL AND ANTI-MICROBIAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/768316 [patent_app_country] => US [patent_app_date] => 2013-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2004 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977414 [patent_doc_number] => 20130210844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/761937 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53633 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8964141 [patent_doc_number] => 20130203743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'FAMCICLOVIR AND MELOXICAM COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES' [patent_app_type] => utility [patent_app_number] => 13/761079 [patent_app_country] => US [patent_app_date] => 2013-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14031 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951308 [patent_doc_number] => 20130197089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF ACTINIC KERATOSIS' [patent_app_type] => utility [patent_app_number] => 13/753783 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1884 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13753783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10521644 [patent_doc_number] => 09248136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Transdermal hormone replacement therapies' [patent_app_type] => utility [patent_app_number] => 14/125554 [patent_app_country] => US [patent_app_date] => 2013-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7828 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125554 [rel_patent_id] =>[rel_patent_doc_number] =>)